Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced a ...
Port and wine producer Symington Family Estates has announced leadership changes including a new joint-CEO pairing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback